Skip to content

Author

Padmini Selvaganesan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Glucagon-like peptide-1 receptor agonism in heart failure with improved ejection fraction; PRAISE-HFiEF

Heart failure with improved ejection fraction (HFimpEF) is an emerging phenotype defined by prior systolic dysfunction with subsequent EF recovery, yet relapse and residual risk remain substantial.1 Obesity and diabetes are prevalent drivers of ongoing risk. GLP-1 receptor agonists (GLP-1RA) improve outcomes in H...

I. Helmy, P. Selvaganesan, M. Karnib et al. · 0 citations
Open access Aug 2026

Clinical effectiveness of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: nationwide cohort study (REFINE-HFpEF)

Abstract Objective To evaluate the clinical effectiveness of sodium glucose cotransporter 2 (SGLT2) inhibitors in reducing the risk of hospital admission for heart failure and mortality in a contemporary nationwide cohort of patients with heart failure with preserved ejection fraction (HFpEF). Design Nationwide cohort...

Padmini Selvaganesan, Mohamad Karnib, Irfan Helmy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.